Niva Bupa Gets IRDAI Nod for Re-Appointment of Mr Krishnan Ramachandran as CEO

In a significant development for Niva Bupa Health Insurance Company Limited, the Insurance Regulatory and Development Authority of India (IRDAI) has formally approved the re-appointment of Mr Krishnan Ramachandran as the Chief Executive Officer and Managing Director. This re-appointment will be effective from 1 May 2025 and continue until 30 April 2030.

Regulatory Approval and Process

According to the company’s communication dated 23 April 2025, the IRDAI granted its approval on 22 April 2025 at 18:23 hours, following the prior endorsement by Niva Bupa’s Board of Directors on 4 February and its shareholders on 28 March 2025. 

The appointment had been subject to regulatory clearance under Section 34A of the Insurance Act, 1938. Niva Bupa confirmed that the application was made in line with legal provisions and that the regulatory authority responded positively with no conditions, penalties, or restrictions.

As per the disclosure made under Regulation 30(13) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the approval does not entail any financial implications for the company and does not reflect any aberrations or non-compliances.

Company Statement and Further Action

In the official filing addressed to the National Stock Exchange of India and BSE Limited, Niva Bupa stated that the details of the re-appointment have been uploaded to the company’s website. Mr Rajat Sharma, Company Secretary and Compliance Officer, affirmed the accuracy and completeness of the submitted information. No further action has been deemed necessary by the company in light of the received communication from the IRDAI.

Read More: Niva Bupa Health Insurance Share Price Jump 22% in Two Sessions: A Look at Recent Developments.

Niva Bupa Share Performance

As of April 24, 2025, 9:50 AM, Niva Bupa share price is trading at ₹85.30, reflecting a 1.83% surge from the previous closing price. Over the past month, the stock has surged by 14.94%.

Conclusion

The re-appointment of Mr Krishnan Ramachandran as CEO & Managing Director has been formally validated by the regulatory authority, allowing Niva Bupa to continue its leadership continuity for the next five years. This decision reaffirms the company’s regulatory compliance and governance standards.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing